Proteins
OpenAI’s GPT-Rosalind is a large language model tuned on common biology workflows and public databases, built to suggest pathways and prioritise drug targets. Citing bioweapon risk, OpenAI is limiting access to vetted US-based researchers for now.
WHY THIS MATTERS IN BRIEF The ability to track the lifecycle of an individual cell down to the nanoscale opens…
WHY THIS MATTERS IN BRIEF AI companies want to automate science and scientific discovery and they’re making progress. Matthew…
WHY THIS MATTERS IN BRIEF AI is already designing drugs and vaccines in minutes, genetic therapies in hours, which makes…
WHY THIS MATTERS IN BRIEF We are seeing synthetic biology and AI converge, and the future could very well be…
WHY THIS MATTERS IN BRIEF We’ve seen a huge increase in the amount of cardboard packaging, but what if you…
WHY THIS MATTERS IN BRIEF By researching the brain’s connectome researchers are hoping it can help them build better AI’s…
WHY THIS MATTERS IN BRIEF While some AI companies are trying to automate scientists and the process of scientific discovery…
WHY THIS MATTERS IN BRIEF Unlike Anti-Ageing tech which halts or delays ageing this is rejuvenation which is the Fountain…
WHY THIS MATTERS IN BRIEF The next frontier of computing isn’t silicon – in fact it’s everything but. Love…
WHY THIS MATTERS IN BRIEF Nanobots small enough to enter brain cells and listen and record what they do is…
WHY THIS MATTERS IN BRIEF AI is slowly starting to understand how life “works” and how to create and manipulate…